Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression

NCT: NCT07274917 · COMPLETED

NCT IDNCT07274917
StatusCOMPLETED
Start Date2026-01-26
Completion2026-06-30
SponsorCapital Medical University (OTHER)
First posted
Last updated

Brief Summary

This study is an clinical trial aimed at evaluating the effectiveness and safety of stereotactic radiotherapy for treatment-resistant depression

Frequently Asked Questions

What is Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression?

Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression is a clinical trial registered under NCT07274917. Current status: COMPLETED.

What is the status of NCT07274917?

The current status of NCT07274917 (Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression) is: COMPLETED.

When did Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression start?

Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression started on 2026-01-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑